Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin

被引:0
|
作者
Trapero-Marugan, M.
Garcia-Buey, L.
Munoz, C.
Moreno-Monteagudo, J. A.
Borque, M. J.
Salcedo-Mora, X.
Moreno-Otero, R.
机构
[1] Hosp Univ Princesa, Gastroenterol & Hepatol Serv, Madrid, Spain
[2] Hosp Univ Princesa, Serv Immunol, Madrid, Spain
[3] Hosp Univ Princesa, Mol Biol Unit, Madrid, Spain
关键词
D O I
10.1016/S0168-8278(06)80613-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
613
引用
收藏
页码:S227 / S228
页数:2
相关论文
共 50 条
  • [1] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Marugán, MT
    Moreno-Otero, R
    Garcia-Buey, L
    Moreno-Monteagudo, JA
    Vitón, M
    Muñoz, C
    Borque, MJ
    Salcedo-Mora, X
    [J]. HEPATOLOGY, 2005, 42 (04) : 668A - 668A
  • [2] Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C (CHC) with pegylated interferon and ribavirin
    Gallegos, JF
    Rakela, J
    Rosati, MJ
    Vargas, H
    Balan, V
    [J]. HEPATOLOGY, 2005, 42 (04) : 565A - 566A
  • [3] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    [J]. Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [4] Ophthalmic findings in chronic hepatitis C (CHC) patients treated with pegylated-interferon (PIFN) and ribavirin (RBV)
    Mehta, N
    Murthy, UK
    Kaul, V
    Abruzzese, GP
    Vadrevu, V
    Sveen, JB
    Teitelbaum, C
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S133 - S133
  • [5] MENOPAUSE IS ASSOCIATED WITH RELAPSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Stern, Christiane
    Martinot-Peignoux, Michelle
    Ripault, Marie-Pierre
    Boyer, Nathalie
    Cardoso, Ana Carolina
    El Ray, Ahmed
    Asselah, Tarik
    Valla, Dominique
    Marcellin, Patrick
    [J]. HEPATOLOGY, 2010, 52 (04) : 788A - 788A
  • [6] Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Garib, Junia Rios
    Garcia, Guilherme Freire
    Teixeira, Rosangela
    Lima e Silva, Francisco das Chagas
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 625 - 631
  • [7] Predictability of response to interferon (IFN) plus ribavirin (RIB) in chronic hepatitis C (CHC) patients.
    Moreno-Monteagudo, JA
    Trapero-Marugan, M
    Garcia-Buey, L
    Borque, MJ
    Moreno-Otero, R
    [J]. HEPATOLOGY, 2002, 36 (04) : 573A - 573A
  • [8] Serum proteome profile to predict virological response in patients with chronic hepatitis C treated by pegylated interferon plus ribavirin
    Paradis, V
    Asselah, T
    Dargere, D
    Ripault, MP
    Martinot, M
    Boyer, N
    Valla, D
    Marcellin, P
    Bedossa, P
    [J]. HEPATOLOGY, 2005, 42 (04) : 444A - 444A
  • [9] Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
    Vispo, Eugenio
    Barreiro, Pablo
    Pineda, Juan A.
    Mira, Jose A.
    Maida, Ivana
    Martin-Carbonero, Luz
    Rodriguez-Novoa, Sonia
    Santos, Ignacio
    Lopez-Cortes, Luis F.
    Merino, Dolores
    Rivero, Antonio
    Soriano, Vincent
    [J]. ANTIVIRAL THERAPY, 2008, 13 (03) : 429 - 437
  • [10] Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
    Abbas, Zaigham
    Tayyab, Ghiasun Nabi
    Qureshi, Mustafa
    Memon, Mohammad Sadik
    Subhan, Amna
    Shakir, Tanzila
    Jafri, Wasim
    Hamid, Saeed
    [J]. HEPATITIS MONTHLY, 2013, 13 (12)